Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) Debt to Equity (2023 - 2025)

Historic Debt to Equity for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $0.29.

  • Onconetix's Debt to Equity rose 484161.23% to $0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.29, marking a year-over-year increase of 484161.23%. This contributed to the annual value of $0.09 for FY2023, which is N/A changed from last year.
  • Onconetix's Debt to Equity amounted to $0.29 in Q3 2025, which was up 484161.23% from $0.01 recorded in Q3 2024.
  • Onconetix's Debt to Equity's 5-year high stood at $0.29 during Q3 2025, with a 5-year trough of -$0.01 in Q1 2024.
  • In the last 3 years, Onconetix's Debt to Equity had a median value of $0.0 in 2023 and averaged $0.05.
  • Per our database at Business Quant, Onconetix's Debt to Equity plummeted by 134287.38% in 2024 and then soared by 484161.23% in 2025.
  • Over the past 3 years, Onconetix's Debt to Equity (Quarter) stood at $0.09 in 2023, then plummeted by 93.15% to $0.01 in 2024, then soared by 4841.61% to $0.29 in 2025.
  • Its Debt to Equity was $0.29 in Q3 2025, compared to $0.01 in Q3 2024 and -$0.0 in Q2 2024.